Skip to content
Low DoseGLP-1Providers

Provider review

SkyRx review

The semaglutide headline requires a year paid upfront.

Reviewed by Lena OrtizMetabolic Health Editor

Price updated October 2026

We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.

Semaglutide $199 monthly equivalent; annual prepay

Visit SkyRx

The semaglutide starting equivalent requires twelve months prepaid and does not specify a microdose.

Price as published

SkyRx

Semaglutide $199 monthly equivalent; annual prepay

Vs median
Not comparable — no per-month rate is published — the verified string carries no monthly figure
Market
$59–$1,300/mo across 299 of 548
Structure
Standard plan, self-directed low dose
Dispensed
Compounded by Pharmxpress; Health Warehouse; BPI Labs; Precision

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

In one paragraph

The verdict

SkyRx’s headline is an annual commitment divided into months. That distinction is central to the buying decision, especially because ending and later restarting a subscription can add a charge. Its semaglutide injection and oral drops are different formulations even though the starting equivalent is the same. Review the full payment, cancellation terms and guarantee conditions before relying on the monthly headline; a microdose-specific saving is not published.

Visit SkyRx

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

Who it suits, and who it does not

A good fit if

  • You are comfortable with a long prepaid treatment commitment
  • You want to discuss injection and oral-drop formulations

Look elsewhere if

  • You need monthly purchasing flexibility
  • You want currently available tirzepatide from this service

What it actually costs

Price as published

Semaglutide $199 monthly equivalent; annual prepay

Vs median
Not comparable — no per-month rate is published — the verified string carries no monthly figure
Market
$59–$1,300/mo is the full published spread on this site
Structure
Standard plan, self-directed low dose

No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.

235 of the 548 programs here price a small dose this way. The semaglutide starting equivalent requires twelve months prepaid and does not specify a microdose.

See SkyRx's current price

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

What is included

Consult
Included in the price
Dietitian
Not confirmed
Labs
Not stated
Pricing
Check plan terms

What it does well

  • The injection and oral-drop options are priced publicly
  • Named pharmacy partners appear in the terms
  • Clinician review and ongoing support accompany the program

Pharmacy, labs and oversight

SkyRx names its pharmacy: Pharmxpress; Health Warehouse; BPI Labs; Precision. Laboratory requirements are not publicly stated; confirm them with the clinician. A clinician review is included in the price.

Transparency check

3 of 4 published openly

What SkyRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.

Pharmacy named and regulatedNames its pharmacy: Pharmxpress; Health Warehouse; BPI Labs; Precision.
Published
A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
Published
What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
Not published
No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
None on file

How the program works

SkyRx offers compounded semaglutide injections and oral drops, with clinician review, medication delivery and ongoing support. Both products carry the same starting monthly equivalent, but the footnote requires a twelve-month subscription paid in full upfront. The reviewed weight-loss page marks tirzepatide injections and drops as coming soon, so they are not treated here as currently available treatments. Pharmacy partners named in the terms include Pharmxpress, Health Warehouse, BPI Labs and Precision. Cancellation requires advance notice, and restarting after cancellation can trigger a reactivation charge. The advertised results guarantee also has substantial adherence and documentation conditions. No separately priced microdose product or weekly dose is attached to the annual offer. The public treatment information does not establish a mandatory laboratory schedule; confirm testing requirements with the clinician.

The honest cons

The starting monthly equivalent requires a full year paid upfront
  • Tirzepatide is advertised as coming soon rather than available
  • Reactivation and guarantee conditions require careful review
Visit SkyRx

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

How it compares

SkyRx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Also consider

Two more programs that price a small dose the way SkyRx does. Both are partners: we may earn a commission if you start care through these links.

Partner

Strut Health

$99/mo sema lozenge (auto-refill)

Standard plan, self-directed low dose

FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.

Partner

Peter MD

$149/mo GLP1+B12 · $249/mo tirz (quarterly)

Standard plan, self-directed low dose

Where this sits

#518 of 548

Ordered with the companies that pay us first, and SkyRx is not one of them. A disclosed partition, not a score.

Compare all 548 providers →

Read this before you buy

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

Start with SkyRx

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

The closest alternative

Willow

From $299/mo covering all four formats, none priced separately

Vs median
$124/mo above the $175 median
Market
$59–$1,300/mo across 299 of 548
Structure
Standard plan, self-directed low dose
Dispensed
Pharmacy not publicly identified

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

Read the Willow review →

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.